Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value

VANCOUVER, Dec. 11, 2019 -- (Healthcare Sales & Marketing Network) - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced plans to explore strategic options to maxi... Biopharmaceuticals, Cardiology, FDA Correvio Pharma, Brinavess, vernakalant, atrial fibrillation
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news